Secondhand smoke exposure among community-dwelling adult cancer survivors in the United States: 1999-2012

Oladimeji Akinboro, Odunayo Olorunfemi, Prasanta Basak, Elizabeth Phillips, Daniel Pomerantz, Bernard Bernhardt, Rasim A. Gucalp, Stephen Jesmajian, Jamie S. Ostroff

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Little is known about the prevalence of secondhand smoke exposure (SHSe) among cancer survivors. We sought to determine the prevalence, trends, and correlates of SHSe among nonsmoking adult cancer survivors in the United States. Methods: Interview and serum cotinine data for nonsmoking adults, age 20 years and older, with a history of cancer (N = 686) were obtained from consecutive two-year cross-sectional cycles of the National Health and Nutrition Examination Survey from 1999 to 2012. SHSe was defined as serum cotinine 0.05-10 ng/mL among nonsmokers. We calculated and trended the prevalence of SHSe among nonsmoking cancer survivors. Multivariable logistic regression was used to examine the associations of SHSe with sociodemographic, smoking, and clinical characteristics. Survey weights were applied in estimating prevalence rates, adjusted ORs, and confidence intervals (CI). Results: The weighted aggregate SHSe and self-reported indoor SHSe prevalence rates over the study period were 28.26% (95% CI: 24.97%-31.55%) and 4.53% (95% CI: 3.48%-5.57%), respectively. SHS exposure declined from 39.61% (95% CI: 27.88%-51.34%) in 1999/2000 to 15.68% (95% CI: 9.38%- 21.98%) in 2011/2012 (Ptrend < 0.001). Age ≥ 60 years was protective against SHSe, while being black, having less than high school education, poverty, and a smoking-related cancer history were associated with higher odds of SHSe. Conclusions: Fortunately, SHSe among nonsmoking cancer survivors in the United States is on the decline, although certain subgroups remain disproportionately burdened. Impact: These findings highlight clinical and public health imperatives to target socioeconomically disadvantaged nonsmoking cancer survivors to reduce their SHSe. Cancer Epidemiol Biomarkers Prev; 26(8); 1296-305.

Original languageEnglish (US)
Pages (from-to)1296-1305
Number of pages10
JournalCancer Epidemiology Biomarkers and Prevention
Volume26
Issue number8
DOIs
StatePublished - Aug 1 2017

Fingerprint

Independent Living
Tobacco Smoke Pollution
Survivors
Neoplasms
Confidence Intervals
Cotinine
Smoking
Nutrition Surveys
Vulnerable Populations
Poverty
Tumor Biomarkers
Serum
Public Health
Logistic Models

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Akinboro, O., Olorunfemi, O., Basak, P., Phillips, E., Pomerantz, D., Bernhardt, B., ... Ostroff, J. S. (2017). Secondhand smoke exposure among community-dwelling adult cancer survivors in the United States: 1999-2012. Cancer Epidemiology Biomarkers and Prevention, 26(8), 1296-1305. https://doi.org/10.1158/1055-9965.EPI-16-0777

Secondhand smoke exposure among community-dwelling adult cancer survivors in the United States : 1999-2012. / Akinboro, Oladimeji; Olorunfemi, Odunayo; Basak, Prasanta; Phillips, Elizabeth; Pomerantz, Daniel; Bernhardt, Bernard; Gucalp, Rasim A.; Jesmajian, Stephen; Ostroff, Jamie S.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 26, No. 8, 01.08.2017, p. 1296-1305.

Research output: Contribution to journalArticle

Akinboro, O, Olorunfemi, O, Basak, P, Phillips, E, Pomerantz, D, Bernhardt, B, Gucalp, RA, Jesmajian, S & Ostroff, JS 2017, 'Secondhand smoke exposure among community-dwelling adult cancer survivors in the United States: 1999-2012', Cancer Epidemiology Biomarkers and Prevention, vol. 26, no. 8, pp. 1296-1305. https://doi.org/10.1158/1055-9965.EPI-16-0777
Akinboro, Oladimeji ; Olorunfemi, Odunayo ; Basak, Prasanta ; Phillips, Elizabeth ; Pomerantz, Daniel ; Bernhardt, Bernard ; Gucalp, Rasim A. ; Jesmajian, Stephen ; Ostroff, Jamie S. / Secondhand smoke exposure among community-dwelling adult cancer survivors in the United States : 1999-2012. In: Cancer Epidemiology Biomarkers and Prevention. 2017 ; Vol. 26, No. 8. pp. 1296-1305.
@article{41412477840541459ef67416d5a3623a,
title = "Secondhand smoke exposure among community-dwelling adult cancer survivors in the United States: 1999-2012",
abstract = "Background: Little is known about the prevalence of secondhand smoke exposure (SHSe) among cancer survivors. We sought to determine the prevalence, trends, and correlates of SHSe among nonsmoking adult cancer survivors in the United States. Methods: Interview and serum cotinine data for nonsmoking adults, age 20 years and older, with a history of cancer (N = 686) were obtained from consecutive two-year cross-sectional cycles of the National Health and Nutrition Examination Survey from 1999 to 2012. SHSe was defined as serum cotinine 0.05-10 ng/mL among nonsmokers. We calculated and trended the prevalence of SHSe among nonsmoking cancer survivors. Multivariable logistic regression was used to examine the associations of SHSe with sociodemographic, smoking, and clinical characteristics. Survey weights were applied in estimating prevalence rates, adjusted ORs, and confidence intervals (CI). Results: The weighted aggregate SHSe and self-reported indoor SHSe prevalence rates over the study period were 28.26{\%} (95{\%} CI: 24.97{\%}-31.55{\%}) and 4.53{\%} (95{\%} CI: 3.48{\%}-5.57{\%}), respectively. SHS exposure declined from 39.61{\%} (95{\%} CI: 27.88{\%}-51.34{\%}) in 1999/2000 to 15.68{\%} (95{\%} CI: 9.38{\%}- 21.98{\%}) in 2011/2012 (Ptrend < 0.001). Age ≥ 60 years was protective against SHSe, while being black, having less than high school education, poverty, and a smoking-related cancer history were associated with higher odds of SHSe. Conclusions: Fortunately, SHSe among nonsmoking cancer survivors in the United States is on the decline, although certain subgroups remain disproportionately burdened. Impact: These findings highlight clinical and public health imperatives to target socioeconomically disadvantaged nonsmoking cancer survivors to reduce their SHSe. Cancer Epidemiol Biomarkers Prev; 26(8); 1296-305.",
author = "Oladimeji Akinboro and Odunayo Olorunfemi and Prasanta Basak and Elizabeth Phillips and Daniel Pomerantz and Bernard Bernhardt and Gucalp, {Rasim A.} and Stephen Jesmajian and Ostroff, {Jamie S.}",
year = "2017",
month = "8",
day = "1",
doi = "10.1158/1055-9965.EPI-16-0777",
language = "English (US)",
volume = "26",
pages = "1296--1305",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

TY - JOUR

T1 - Secondhand smoke exposure among community-dwelling adult cancer survivors in the United States

T2 - 1999-2012

AU - Akinboro, Oladimeji

AU - Olorunfemi, Odunayo

AU - Basak, Prasanta

AU - Phillips, Elizabeth

AU - Pomerantz, Daniel

AU - Bernhardt, Bernard

AU - Gucalp, Rasim A.

AU - Jesmajian, Stephen

AU - Ostroff, Jamie S.

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Background: Little is known about the prevalence of secondhand smoke exposure (SHSe) among cancer survivors. We sought to determine the prevalence, trends, and correlates of SHSe among nonsmoking adult cancer survivors in the United States. Methods: Interview and serum cotinine data for nonsmoking adults, age 20 years and older, with a history of cancer (N = 686) were obtained from consecutive two-year cross-sectional cycles of the National Health and Nutrition Examination Survey from 1999 to 2012. SHSe was defined as serum cotinine 0.05-10 ng/mL among nonsmokers. We calculated and trended the prevalence of SHSe among nonsmoking cancer survivors. Multivariable logistic regression was used to examine the associations of SHSe with sociodemographic, smoking, and clinical characteristics. Survey weights were applied in estimating prevalence rates, adjusted ORs, and confidence intervals (CI). Results: The weighted aggregate SHSe and self-reported indoor SHSe prevalence rates over the study period were 28.26% (95% CI: 24.97%-31.55%) and 4.53% (95% CI: 3.48%-5.57%), respectively. SHS exposure declined from 39.61% (95% CI: 27.88%-51.34%) in 1999/2000 to 15.68% (95% CI: 9.38%- 21.98%) in 2011/2012 (Ptrend < 0.001). Age ≥ 60 years was protective against SHSe, while being black, having less than high school education, poverty, and a smoking-related cancer history were associated with higher odds of SHSe. Conclusions: Fortunately, SHSe among nonsmoking cancer survivors in the United States is on the decline, although certain subgroups remain disproportionately burdened. Impact: These findings highlight clinical and public health imperatives to target socioeconomically disadvantaged nonsmoking cancer survivors to reduce their SHSe. Cancer Epidemiol Biomarkers Prev; 26(8); 1296-305.

AB - Background: Little is known about the prevalence of secondhand smoke exposure (SHSe) among cancer survivors. We sought to determine the prevalence, trends, and correlates of SHSe among nonsmoking adult cancer survivors in the United States. Methods: Interview and serum cotinine data for nonsmoking adults, age 20 years and older, with a history of cancer (N = 686) were obtained from consecutive two-year cross-sectional cycles of the National Health and Nutrition Examination Survey from 1999 to 2012. SHSe was defined as serum cotinine 0.05-10 ng/mL among nonsmokers. We calculated and trended the prevalence of SHSe among nonsmoking cancer survivors. Multivariable logistic regression was used to examine the associations of SHSe with sociodemographic, smoking, and clinical characteristics. Survey weights were applied in estimating prevalence rates, adjusted ORs, and confidence intervals (CI). Results: The weighted aggregate SHSe and self-reported indoor SHSe prevalence rates over the study period were 28.26% (95% CI: 24.97%-31.55%) and 4.53% (95% CI: 3.48%-5.57%), respectively. SHS exposure declined from 39.61% (95% CI: 27.88%-51.34%) in 1999/2000 to 15.68% (95% CI: 9.38%- 21.98%) in 2011/2012 (Ptrend < 0.001). Age ≥ 60 years was protective against SHSe, while being black, having less than high school education, poverty, and a smoking-related cancer history were associated with higher odds of SHSe. Conclusions: Fortunately, SHSe among nonsmoking cancer survivors in the United States is on the decline, although certain subgroups remain disproportionately burdened. Impact: These findings highlight clinical and public health imperatives to target socioeconomically disadvantaged nonsmoking cancer survivors to reduce their SHSe. Cancer Epidemiol Biomarkers Prev; 26(8); 1296-305.

UR - http://www.scopus.com/inward/record.url?scp=85026845231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026845231&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-16-0777

DO - 10.1158/1055-9965.EPI-16-0777

M3 - Article

C2 - 28642231

AN - SCOPUS:85026845231

VL - 26

SP - 1296

EP - 1305

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 8

ER -